Virtual Instrument Development and Test Suite

"MRC's Phase II objective will be to enable DARPA to resolve the issue of BioFlips and Simbiosys technology developers not having access to quantitative, prioritized set of user requirements to design against. The Phase II product will be the expansion ofour Phase I VIDTS requirements analysis software into a tailored requirements management tool and requirements database that will enable DARPA supported developers to better design and implement to the needs of key end users and government instrumentdevelopment agencies. For Phase II, we will complete VIDTS development by integrating a customer-driven requirements database with the instrument and module design and optimization package. We will capture requirements through user meetings with our teamof an IT expert, a microsystems expert, and a systems engineering expert, by coordinating splinter sessions at DARPA PI meetings to refine requirements and technology development paths for key case studies, and through a web site dedicated to performinginformation outreach and exchange between the developers and end users. MRC will complete the development of the VIDTS architecture and will provide interfaces to other microsystem modeling software. The completed architecture will be scalable,extensible, and web-based for ease of use. The requirements database will be integrated as a separate, upgradeable library."